Header Logo

Connection

Raid Aljumaily to Carcinoma, Transitional Cell

Back to Details
This is a "connection" page, showing publications Raid Aljumaily has written about Carcinoma, Transitional Cell.
Raid Aljumaily
Connection Strength
0.176
Carcinoma, Transitional Cell
  1. Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis. J Immunother Cancer. 2020 10; 8(2).
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.